Puerperal Disorders: Clinical Trials

2 trials for Puerperal Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2
Phase 21Terminated 1

Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression
Celecoxib, Placebo - Bipolar Disorder, Postpartum Depression
Phase 3TerminatedLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's12016-05-012022-01-20
Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
Ferric carboxymaltose, Ferrous sulfate tablets - Anemia, Iron-Deficiency, Puerperal Disorders
Phase 2 / Phase 3TerminatedNorwegian University of Science and Technology302009-06-012012-02-17

Narrower conditions

Depression, Postpartum (2)  ·  Anemia, Iron-Deficiency (1)  ·  Bipolar Disorder (1)

Broader conditions

Depressive Disorder (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Mental Disorders (2)  ·  Mood Disorders (2)  ·  Pregnancy Complications (2)  ·  Urogenital Diseases (2)  ·  Anemia (1)  ·  Anemia, Hypochromic (1)  ·  Bipolar and Related Disorders (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Iron Deficiencies (1)  ·  Iron Metabolism Disorders (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Celecoxib (1)  ·  Iron-Dextran Complex (1)  ·  ferric carboxymaltose (1)

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1)  ·  Norwegian University of Science and Technology (1)

Countries

Canada (1)  ·  Norway (1)

Top investigators

Bjorn Backe, MD PhD (1)  ·  Verinder Sharma, MB BS (1)

NIH funding

2008 (1)